iScience (Oct 2022)

Cbl-b restrains priming of pathogenic Th17 cells via the inhibition of IL-6 production by macrophages

  • Qiuming Zeng,
  • Na Tang,
  • Yilei Ma,
  • Hui Guo,
  • Yixia Zhao,
  • Rong Tang,
  • Chengkai Yan,
  • Song Ouyang,
  • Wallace Y. Langdon,
  • Huan Yang,
  • Matthew C. O’Brien,
  • Jian Zhang

Journal volume & issue
Vol. 25, no. 10
p. 105151

Abstract

Read online

Summary: E3 ubiquitin ligase Cbl-b is involved in the maintenance of a balance between immunity and tolerance. Mice lacking Cbl-b are highly susceptible to experimental autoimmune encephalomyelitis (EAE), a Th17-mediated autoimmune disease. However, how Cbl-b regulates Th17 cell responses remains unclear. In this study, utilizing adoptive transfer and cell type-specific Cblb knockout strains, we show that Cbl-b expression in macrophages, but not T cells or dendritic cells (DCs), restrains the generation of pathogenic Th17 cells and the development of EAE. Cbl-b inhibits IL-6 production by macrophages that is induced by signaling from CARD9-dependent C-type lectin receptor (CLR) pathways, which directs T cells to generate pathogenic Th17 cells. Therefore, our data unveil a previously unappreciated function for Cbl-b in the regulation of pathogenic Th17 responses.

Keywords